Tweaking the pirfenidone molecule yields an evidently effective but less toxic antifibrotic drug, investigators say.

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.

Only one fourth of sunscreens on store shelves in the United States deliver safe and effective protection against the harmful rays of the sun, according<a class="excerpt-read-more" href=" More ...

Doctors, environmental groups and residents are trying to determine if there is a causal connection between pollutants from ...

In the barren drug development landscape, Amplia Therapeutics is making strides with its candidate that works on the ...

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd).

At the World Conference on Lung Cancer (WCLC) in San Diego, interim results from the dose optimisation part of the Ideate-Lung01 trial showed the benefit of the 12 mg/kg dose of the antibody-drug ...

COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...